Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Efficacy of Ayurveda Formulation Ayush-82 (IME-9) in Newly Diagnosed Type 2 Diabetics: Retrospective Analysis of Individual Data
Ashok Kumar Panda1*, KK Ratha1 and MM Rao21Research Officer (Ayurveda), Centralleal Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar -751029, CCRAS, M/O AYUSH, Govt Of India.
2Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar-751029, Odisha, India
- *Corresponding Author:
- Ashok Kumar Panda
Research Officer (Ayurveda)
Centralleal Ayurveda Research Institute of Hepatobiliary Disorders
Bharatpur, Bhubaneswar -751029, CCRAS
M/O AYUSH, Govt Of India
Tel: 03592-231494
E-mail: akpanda_06@yahoo.co.in
Received date: October 04, 2017; Accepted date: November 08, 2017; Published date: November 08, 2017
Citation: Panda AK, KK Ratha, MM Rao (2017) Efficacy of Ayurveda Formulation Ayush-82 (IME-9) in Newly Diagnosed Type 2 Diabetics: Retrospective Analysis of Individual Data. J Tradit Med Clin Natur 6:250.
Copyright: © 2017 Panda AK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Ayush 82 is formulated and clinically proven by Central Council Research in Ayurveda Sciences, M/o of AYUSH, GOI for diabetic care. Recently Right Sugar (Chaturbhuj Pharmaceutical), IME-9 (Kudos Ayurveda) and BGR-34 (AIMIL Pharmaceutical) have drawn the attention of many diabetic consumers as these products are developed from scientific organizations of government and highlighted in electronic and print media. IME-9 (Kudos Ayurveda) developed from Ayush 82 of Central Council Research in Ayurveda Sciences, M/o of AYUSH, GOI. Most of the patients consuming IME-9 attend Ayurvedic hospitals and clinics for evaluation of their blood sugar level to know the efficacy of the drug and for consultation. Therefore, an initiative was taken to analyze the safety and efficacy of IME-9 in newly diagnosed diabetic patients taking an IME-9 tablet or have a primary prescription of the same. IME-9 was able to reduce (96%) the blood glucose of all newly diagnosed cases, whereas glycosylated haemoglobin level was reduced in all newly diagnosed cases except in one. Total 12 (48%) patients have shown the improvement of blood glucose and glycosylated haemoglobin (up to 7). It is also observed that in three cases blood glucose level was increased after 2 weeks of treatment and significant reduction of blood glucose was found after the 8th week. So IME-9 may be the first line choice of herbal treatment of newly diagnosed cases along with a change in lifestyle.
